Co-Diagnostics (Co-Dx) yesterday held a ribbon-cutting ceremony to celebrate the grand opening of the company’s new manufacturing facility, located at 3222 S. Washington St. in South Salt Lake. South Salt Lake Mayor Cherie Wood, Lance Soffe and Jim Grover with the Governor’s Office of Economic Opportunity, David Carlebach with World Trade Center Utah, representatives from […]

Multiplier Advisors and Tideline today announced a strategic partnership to support health-focused impact investors—such as healthcare organizations, insurers, and foundations—that are directing investable assets to address social determinants of health (SDOH) while targeting the alignment of financial, business, and community impact performance. Through this partnership, Multiplier and Tideline are aiming to unlock $5 billion of […]

Canary Speech and CareLink360 Form Partnership to Support Family Caregivers and the Aging Adults They Care For. Flemington, NJ – April 8, 2024 – Today we are excited to announce a new partnership between Canary Speech, an AI-driven vocal biomarker health company and CareLink360, a digital health, AgeTech, and data analytics insights company, to support family […]

The C-Blu team’s device provides greater visual contrast to potentially cancerous lesions, enabling improved accuracy for clinicians during the screening process. Despite a crowded field of over 30 other entries, the C-Blu team rose to the top to be named the Grand Prize Winner at the 14th Annual Bench to Bedside Competition on Monday night […]

VALENCIA, Calif. – April 10, 2024 – Nusano, a physics company transforming the production of medical radioisotopes, today announced it will attend and present at Jefferies Radiopharma Innovation Summit in New York City on Thursday, April 11, 2024. In his presentation, Nusano CEO Chris Lowe will provide an update on the company’s commercialization plans, including […]

Fewer patients were prescribed medications with gene-drug interactions after taking the GeneSight test SALT LAKE CITY, April 09, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, revealed results from a multi-year, real-world study of nearly 21,000 patients that indicated those with major depressive disorder had reduced […]

LONDON and SALT LAKE CITY, April 08, 2024 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces a registered direct offering of ordinary shares at a purchase price equivalent to $0.75 per NASDAQ ADS ($0.375 per common stock share) (£0.0025 each) (the “Ordinary Shares”) (the “Fundraise”) to DB Capital Partners Healthcare, L.P. (the “Purchaser”), […]

FRANKLIN LAKES, N.J., April 9, 2024 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will receive the Business Group on Health “Best Employers: Excellence in Health & Well-being Award” for its commitment to advancing employee well-being through comprehensive and innovative benefits and initiatives. BD also […]